EXPLORE!

Medical Voice 14th August 2020

  730 Views

Dr KK Aggarwal    14 August 2020

Common BP drugs dont increase COVID-19 severity: Study

Washington: A class of drugs that is commonly used to treat patients with hypertension, and heart disease does not increase the risk of developing severe COVID-19 as previously feared, according to a study in mice. Scientists, including those from Northwestern University in the US, said there have been widespread concerns that the drugs -- ACE inhibitors and angiotensin receptor blockers (ARB) -- might cause an increase in the human cell surface receptor protein ACE2 which the novel coronavirus uses to enter and infect cells. Earlier studies had cautioned that this class of drugs could possibly increase the risk for the novel coronavirus, SARS-CoV-2, infection and elevate COVID-19 severity. However, the new findings, published in the Journal of the American Society of Nephrology, revealed a decrease, not an increase, in ACE2 in mice kidney membranes, and no change in lung membranes. ....read more

 

Chest Pain in COVID Era

Join us today as we discuss about chest pain and it’s management in COVID era on Medtalks with Dr K K Aggarwal COVID edition at 7:00 pm.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php

CMAAO Coronavirus Facts and Myth Buster: Human Challenge Trials

With inputs from Dr Monica Vasudev1047: Human Challenge Trials for COVID-19 Vaccine and the RiskHuman challenge trials for the COVID-19 vaccine — These trials involve volunteering to receive an unproven vaccine, being exposed to the virus deliberately, instead of waiting to be exposed and for infection to occur naturally in the community. The goal of such trials is to hasten vaccine development. Over 32,000 people from the United States and 139 other countries have signed up with an online registry, 1Day Sooner. The trials could pave the way for delivering a vaccine and end the pandemic more quickly; however, there are several unknowns associated with this novel coronavirus, besides the lack of an effective treatment.The extra risk could come at a high cost – that of health, or potentially the life, of the volunteers. ....read more

 

World COVID Meter 12th August, Acute immuno-inflammatory manageable virus disease with significant post-viral phase; 213 Countries Affected

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10thJanuary; Total cases are based on RT-PCR, 67% sensitivity Coronavirus Cases: 20,504,855,Deaths: 744,695,Recovered: 13,427,265 ,ACTIVE CASES 6,332,895,Currently Infected Patients 6,268,443 (99%) in Mild Condition....read more

 

Negative thoughts are absence of positive thoughts

Darkness cannot be removed physically; it can only be removed by switching light or going into sunlight or lighting fire. Similarly, negative thoughts are absence of positive thoughts. In Bhagavad Gita also, it has been said that the period of Uttarayana with longer days, the first half at full moon, in the presence of light or agni, one acquires more positive thoughts as compared in Dakshinayana before Amavasya or no moon or in absence of light. Bhagavad Gita also says that whatever you think the whole life, you think at the time of death and if at the time of death you have positive thoughts, you are likely to get Moksha. That may be the reason why in Hindu mythology it is said that just before the death, we should light a diya or chant in front of agni (fire) so that dying person’s thoughts become positive. ....read more

 

Video of The day

Do not ignore extreme tiredness in COVID 19

Healthcare News Monitor

Remdesivir shortage is India is easing: Cipla

Express Pharma

India’s supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID-19 medicine at hospitals, said Kedar Upadhye, Global Chief Financial Officer, Cipla. Cipla’s launch of remdesivir in late June, along with subsequent launches by others, has helped ease supply bottlenecks in India, said Upadhye. India, one of the world’s biggest producer of generic drugs, recommends remdesivir for moderate to severe COVID-19. Doctors also use other drugs, including favipiravir, another antiviral approved for the disease. Cipla, which is also free to export the drug, supplies it in South Africa and plans to expand access to “several sub-Saharan African countries”.

Zydus Cadila launches COVID-19 drug Remdesivir in India

Outlook India

New Delhi, Aug 13 (PTI) Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing. The company said the drug will be made available across India through the groups strong distribution chain reaching out to government and private hospitals treating COVID-19 patients. “Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19,†Cadila Healthcare Managing Director Dr Sharvil Patel said.

District doctor on leave, how this Mizoram MLA helped a woman deliver baby

The Indian Express

Setting an example of humanitarian service, Mizoram MLA ZR Thiamsanga, who was on a visit to his constituency in Champhai district to take stock of the earthquake-hit areas, performed an emergency surgery to help a woman deliver a baby when he was informed that no doctor was available to attend to her. The incident occurred on Monday when Thiamsanga, a doctor by profession who specialises in obstetrics and gynaecology, was on a visit to Champhai district to assess the damages caused by a series of mild earthquakes in the area and oversee the Covid-19 situation. In the morning, the MLA was informed that a pregnant woman was in a critical situation.

Calcutta police to contact doctors from IMA list for families in isolation

The Indian Medical Association has sent Calcutta police the names of doctors who can be contacted by officers at police stations if families of Covid-19 patients in home isolation need any medical help. Officers clarified that the families can approach the local police stations for any emergency related to any member, not just the Covid patients. The list has tagged two to four doctors with every police station. The doctors either live or work in the areas guarded by the respective police stations, said a member of the association.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.